What is Sett?
Founded in 2025, Sett operates within the consumer non-durables industry, focusing on the development of innovative nicotine alternatives. The company's flagship product, the "productivity pouch," is formulated with proprietary, tobacco-free alkaloids like Ceretinea and L-Theanine, designed to enhance focus and mood. Sett distinguishes itself through a commitment to health-conscious formulations, ensuring its pouches are pH neutral to mitigate gum irritation and providing transparent ingredient labeling. The company actively collaborates with medical professionals and performance experts to position its offerings as a superior, healthier alternative to conventional nicotine products.
How much funding has Sett raised?
Sett has raised a total of $3.8M across 1 funding round:
Other Financing Round
$3.8M
Other Financing Round (2025): $3.8M with participation from JAZZ Venture Partners
Key Investors in Sett
JAZZ Venture Partners
JAZZ Venture Partners is a venture capital firm that invests in technologies aimed at enhancing human performance across various sectors, including healthcare, wellness, and consumer markets. The firm collaborates with early and growth-stage companies to drive innovation at the intersection of technology, science, and humanity.
What's next for Sett?
The recent major strategic investment signals a pivotal growth phase for Sett. This capital is expected to fuel further product development, market expansion, and potentially broader distribution channels. The company's focus on health-conscious formulations and transparent ingredient sourcing aligns with evolving consumer preferences for wellness-oriented products, positioning Sett for significant traction in the competitive consumer non-durables market. Future endeavors will likely involve scaling production, enhancing marketing efforts, and potentially exploring new product lines that leverage their proprietary formulations.
See full Sett company page
